Calton & Associates’s Exelon EXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$259K Sell
5,545
-94
-2% -$4.35K 0.04% 347
2026
Q1
$276K Buy
5,639
+19
+0.3% +$884 0.04% 338
2025
Q4
$245K Buy
5,620
+21
+0.4% +$958 0.04% 378
2025
Q3
$252K Buy
5,599
+20
+0.4% +$878 0.04% 362
2025
Q2
$242K Sell
5,579
-36
-0.6% -$1.6K 0.04% 323
2025
Q1
$259K Buy
+5,615
New +$235K 0.06% 263
2024
Q4
Sell
-5,466
Closed -$222K 220
2024
Q3
$222K Buy
+5,466
New +$206K 0.08% 205
2023
Q3
Sell
-5,456
Closed -$222K 156
2023
Q2
$222K Buy
5,456
+25
+0.5% +$1.03K 0.1% 182
2023
Q1
$228K Sell
5,431
-79
-1% -$3.29K 0.11% 194
2022
Q4
$238K Buy
5,510
+109
+2% +$4.31K 0.09% 235
2022
Q3
$202K Sell
5,401
-8
-0.1% -$354 0.12% 193
2022
Q2
$245K Sell
5,409
-96
-2% -$4.51K 0.14% 181
2022
Q1
$262K Sell
5,505
-2,193
-28% -$92.9K 0.08% 282
2021
Q4
$317K Buy
7,698
+152
+2% +$5.72K 0.08% 250
2021
Q3
$260K Buy
7,546
+23
+0.3% +$786 0.06% 317
2021
Q2
$238K Buy
7,523
+14
+0.2% +$451 0.05% 342
2021
Q1
$234K Sell
7,509
-581
-7% -$17.5K 0.05% 341
2020
Q4
$244K Buy
8,090
+16
+0.2% +$472 0.04% 312
2020
Q3
$206K Buy
8,074
+18
+0.2% +$477 0.04% 313
2020
Q2
$209K Buy
8,056
+146
+2% +$3.88K 0.05% 298
2020
Q1
$208K Buy
7,910
+105
+1% +$3.3K 0.05% 265
2019
Q4
$254K Buy
7,805
+1,702
+28% +$55.1K 0.05% 295
2019
Q3
$210K Sell
6,103
-3,089
-34% -$104K 0.05% 307
2019
Q2
$314K Sell
9,192
-4,954
-35% -$175K 0.09% 190
2019
Q1
$506K Buy
14,146
+6,372
+82% +$217K 0.15% 128
2018
Q4
$250K Buy
+7,774
New +$249K 0.09% 189
2018
Q2
Sell
-10,225
Closed -$284K 328
2018
Q1
$284K Hold
10,225
0.08% 242
2017
Q4
$281K Buy
+10,225
New +$294K 0.07% 258

Other funds holding EXC

Calton & Associates's EXC Position: Q2 2026 in Review

Calton & Associates reduced its Exelon (EXC) stake by 1.7% in Q2 2026, selling an estimated $4.35K and leaving 5,545 shares worth $259K. The position accounts for 0.04% of the portfolio, ranked #347.

Calton & Associates first reported a position in EXC in Q4 2017 and has held it in 28 quarters since. The position peaked at $506K in Q1 2019. 1,287 funds tracked by Wall St. Rank hold EXC as of Q2 2026.

  • Calton & Associates held 5,545 shares of Exelon worth $259K as of Q2 2026.
  • Calton & Associates sold 94 Exelon shares in Q2 2026, an estimated $4.35K.
  • Exelon made up 0.04% of Calton & Associates's portfolio in Q2 2026, its #347 holding.
  • Calton & Associates first reported a position in Exelon in Q4 2017 and has held it in 28 quarters since.
  • Calton & Associates's Exelon position peaked at $506K in Q1 2019.
  • 1,287 funds tracked by Wall St. Rank held Exelon as of Q2 2026.

Based on Calton & Associates's 13F filing for Q2 2026, filed 10 Aug 2026.